APOB and cardiovascular disorder: Similar to these findings, a resveratrol-enriched (4–80 mg/g) grape extract supplemented for six months lowered the pro-atherosclerotic molecules and oxidized LDL (LDLox) and apolipoprotein B (ApoB) more so than a non-resveratrol-enriched grape extract or a placebo control in primary cardiovascular disease prevention (PCP) patients [58].